In a significant move to bolster Nigeria's pharmaceutical sector, the Pharmaceutical Manufacturers Group of Nigeria (PMG-MAN) is advocating for local drug production to reach 70% by 2027. This initiative aims to diminish the nation’s reliance on imported medications, a dependency that has been exacerbated by global supply chain disruptions and rising costs.
PMG-MAN's push comes at a critical time when Nigeria's healthcare system is under pressure, highlighting the necessity for self-sufficiency in drug production. The group has urged the government to implement policies that support local manufacturers, ensuring they can compete effectively with foreign companies. According to PMG-MAN President, Dr. Adebayo Adefemi, "Increasing local production is not just an economic necessity but a matter of national security in health."
Looking ahead, if the Nigerian government responds favorably, this initiative could transform the landscape of healthcare in the country, potentially creating jobs, improving access to essential medicines, and enhancing overall public health outcomes. Success in achieving this ambitious target would mark a pivotal shift towards a more resilient and independent pharmaceutical industry in Nigeria.